Cargando…
Screening for Susceptibility-Related Factors and Biomarkers of Xianling Gubao Capsule-Induced Liver Injury
Although increasing reports from the literature on herbal-related hepatotoxicity, the identification of susceptibility-related factors and biomarkers remains challenging due to idiosyncratic drug-induced liver injury (IDILI). As a well-known Chinese medicine prescription, Xianling Gubao Capsule (XLG...
Autores principales: | Li, Chun-yu, Niu, Ming, Liu, Ya-lei, Tang, Jin-fa, Chen, Wei, Qian, Geng, Zhang, Ming-yu, Shi, Ya-fei, Lin, Jun-zhi, Li, Xing-jie, Li, Rui-sheng, Xiao, Xiao-he, Li, Guo-hui, Wang, Jia-bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274038/ https://www.ncbi.nlm.nih.gov/pubmed/32547402 http://dx.doi.org/10.3389/fphar.2020.00810 |
Ejemplares similares
-
Xianling Gubao Capsule Prevents Cadmium-Induced Kidney Injury
por: Huang, Jian, et al.
Publicado: (2021) -
Comparative Efficacy of Xianling Gubao Capsules in Improving Bone Mineral Density in Postmenopausal Osteoporosis: A Network Meta-Analysis
por: Luo, Ming-hui, et al.
Publicado: (2022) -
Chinese herbal medicine Xianling Gubao capsule for knee osteoarthritis: A protocol for systematic review and meta-analysis
por: Liu, Wang, et al.
Publicado: (2022) -
Chinese Proprietary Medicine Xianling Gubao Capsule for Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Cheng, Bai-Ru, et al.
Publicado: (2022) -
Efficacy of Xianling Gubao capsule in treating sarco-osteopenia: Protocol for a systematic review and meta-analysis
por: Chen, Qunqun, et al.
Publicado: (2019)